Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Benzo[e]pyridoindoles, novel inhibitors of the aurora kinasesThi My-Nhung Hoang, Bertrand Favier, Annie Valette, et al.Langmuir : the ACS Journal of Surfaces and Colloids|February 6, 2014
Simulated adhesion between realistic hydrocarbon materials: effects of composition, roughness, and contact pointKathleen E Ryan, Pamela L Keating, Tevis D B Jacobs, et al.Journal of Photochemistry and Photobiology. B, Biology|June 13, 2006
Pharmacokinetics of a tri-glucoconjugated 5,10,15-(meta)-trihydroxyphenyl-20-phenyl porphyrin photosensitizer for PDT. A single dose study in the ratMarie-Catherine Desroches, Antonia Bautista-Sanchez, Claire Lamotte, et al.ACS Applied Materials & Interfaces|September 30, 2017
Tribochemical Wear of Diamond-Like Carbon-Coated Atomic Force Microscope TipsJingjing Liu, Yijie Jiang, David S Grierson, et al.Journal of Medicinal Chemistry|August 4, 2009
Synthesis and biological evaluation of C-5 methyl substituted 4-arylthio and 4-aryloxy-3-Iodopyridin-2(1H)-one type anti-HIV agentsJérôme Guillemont, Abdellah Benjahad, Said Oumouch, et al.Journal of Medicinal Chemistry|February 16, 2016
A Parallel Synthesis Approach to the Identification of Novel Diheteroarylamide-Based Compounds Blocking HIV Replication: Potential Inhibitors of HIV-1 Pre-mRNA Alternative SplicingPeter K Cheung, David Horhant, Laura E Bandy, et al.Nucleic Acids Research|December 9, 2016
Modulation of the splicing regulatory function of SRSF10 by a novel compound that impairs HIV-1 replicationLulzim Shkreta, Marco Blanchette, Johanne Toutant, et al.Journal of Medicinal Chemistry|July 19, 2018
Development of Novel Monoamine Oxidase-B (MAO-B) Inhibitors with Reduced Blood-Brain Barrier Permeability for the Potential Management of Noncentral Nervous System (CNS) DiseasesRonan Gealageas, Alice Devineau, Pauline P L So, et al.Journal of Medicinal Chemistry|October 16, 2004
4-benzyl- and 4-benzoyl-3-dimethylaminopyridin-2(1H)-ones, a new family of potent anti-HIV agents: optimization and in vitro evaluation against clinically important HIV mutant strainsAbdellah Benjahad, Karine Courté, Jérôme Guillemont, et al.NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.Pageof 5